Stay updated on Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.5, replacing the previous v3.6.4, signaling a minor software update of the site interface. This change is metadata about the page rather than alterations to study content or eligibility information.
    Difference
    0.0%
    Check dated 2026-08-11T16:11:05.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Investigator Inquiry Form was removed from the page. Users can still contact the study team using the listed contacts and locations.
    Difference
    0.0%
    Check dated 2026-08-04T06:45:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.4, replacing the previous v3.6.3. This reflects a minor system update to the page rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-07-28T05:37:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision indicator was bumped from v3.6.2 to v3.6.3, signaling a minor update to the study record.
    Difference
    0.0%
    Check dated 2026-07-06T16:44:52.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.0 to v3.6.2, indicating the page has been rebuilt or updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-29T10:52:09.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The study details page adds a recruitment status indicator stating no participants are being recruited and introduces new guidance sections for reading the study record, common questions, and how to join a study. The Intervention/Treatment label is standardized, and a new site revision tag (v3.6.0) is shown, while the older revision tag is removed.
    Difference
    0.3%
    Check dated 2026-06-14T22:49:29.000Z thumbnail image

Stay in the know with updates to Nivolumab in Relapsed/Refractory DLBCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Relapsed/Refractory DLBCL Clinical Trial page.